BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8284226)

  • 1. Evaluation of some properties of a phosphorodithioate oligodeoxyribonucleotide for antisense application.
    Ghosh MK; Ghosh K; Dahl O; Cohen JS
    Nucleic Acids Res; 1993 Dec; 21(24):5761-6. PubMed ID: 8284226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorothioate-phosphodiester oligonucleotide co-polymers: assessment for antisense application.
    Ghosh MK; Ghosh K; Cohen JS
    Anticancer Drug Des; 1993 Feb; 8(1):15-32. PubMed ID: 8386513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of antisense DNA: comparison of activity of anti-rabbit beta-globin oligodeoxyribonucleoside phosphorothioates with computer predictions of mRNA folding.
    Jaroszewski JW; Syi JL; Ghosh M; Ghosh K; Cohen JS
    Antisense Res Dev; 1993; 3(4):339-48. PubMed ID: 8155975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligonucleotide-poly-L-ornithine conjugates: binding to complementary DNA and RNA.
    Zhu T; Wei Z; Tung CH; Dickerhof WA; Breslauer KJ; Georgopoulos DE; Leibowitz MJ; Stein S
    Antisense Res Dev; 1993; 3(3):265-75. PubMed ID: 8286927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of anti-RNA properties of normal and ellipticine functionalized alpha and beta-oligonucleotides.
    Lavignon M; Bertrand JR; Porumb H; Rayner B; Imbach JL; Paoletti C; Malvy C
    Nucleic Acids Symp Ser; 1991; (24):117-9. PubMed ID: 1668683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9-Aminoellipticine-derivatized alpha- and beta-oligodeoxyribonucleotides targeted to the cap of beta-globin mRNA: hybridization to natural and engineered mRNA, inhibition of translation, and improved effect of tandem chains.
    Porumb H; Bertrand JR; Paoletti J; Vasseur JJ; Rayner B; Imbach JL; Malvy C
    Antisense Res Dev; 1992; 2(4):279-92. PubMed ID: 1292777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNase H-mediated inhibition of translation by antisense oligodeoxyribonucleotides: use of backbone modification to improve specificity.
    Larrouy B; Blonski C; Boiziau C; Stuer M; Moreau S; Shire D; Toulmé JJ
    Gene; 1992 Nov; 121(2):189-94. PubMed ID: 1332911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified oligonucleotides in rabbit reticulocytes: uptake, stability and antisense properties.
    Boiziau C; Toulmé JJ
    Biochimie; 1991 Nov; 73(11):1403-8. PubMed ID: 1799634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligodeoxynucleotide analogs as informational drugs to regulate translation.
    Ghosh M; Ghosh K; Cohen JS
    Nucleic Acids Symp Ser; 1991; (24):139-42. PubMed ID: 1668685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides.
    Cazenave C; Stein CA; Loreau N; Thuong NT; Neckers LM; Subasinghe C; Hélène C; Cohen JS; Toulmé JJ
    Nucleic Acids Res; 1989 Jun; 17(11):4255-73. PubMed ID: 2472605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translation inhibition by phosphorothioate oligodeoxynucleotides in cell-free systems.
    Ghosh MK; Ghosh K; Cohen JS
    Antisense Res Dev; 1992; 2(2):111-8. PubMed ID: 1327332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism.
    Boiziau C; Kurfurst R; Cazenave C; Roig V; Thuong NT; Toulmé JJ
    Nucleic Acids Res; 1991 Mar; 19(5):1113-9. PubMed ID: 1850511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed backbone antisense oligonucleotides: design, biochemical and biological properties of oligonucleotides containing 2'-5'-ribo- and 3'-5'-deoxyribonucleotide segments.
    Kandimalla ER; Manning A; Zhao Q; Shaw DR; Byrn RA; Sasisekharan V; Agrawal S
    Nucleic Acids Res; 1997 Jan; 25(2):370-8. PubMed ID: 9016567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and physicochemical properties of phosphorodithioate DNA.
    Cummins L; Graff D; Beaton G; Marshall WS; Caruthers MH
    Biochemistry; 1996 Jul; 35(26):8734-41. PubMed ID: 8679636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A specificity comparison of four antisense types: morpholino, 2'-O-methyl RNA, DNA, and phosphorothioate DNA.
    Stein D; Foster E; Huang SB; Weller D; Summerton J
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):151-7. PubMed ID: 9212905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2D 1H and 31P NMR spectra and distorted A-DNA-like duplex structure of a phosphorodithioate oligonucleotide.
    Cho Y; Zhu FC; Luxon BA; Gorenstein DG
    J Biomol Struct Dyn; 1993 Dec; 11(3):685-702. PubMed ID: 8129879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of antisense oligonucleotides stabilized by locked nucleic acids.
    Kurreck J; Wyszko E; Gillen C; Erdmann VA
    Nucleic Acids Res; 2002 May; 30(9):1911-8. PubMed ID: 11972327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrimidine phosphorothioate oligonucleotides form triple-stranded helices and promote transcription inhibition.
    Xodo L; Alunni-Fabbroni M; Manzini G; Quadrifoglio F
    Nucleic Acids Res; 1994 Aug; 22(16):3322-30. PubMed ID: 8078767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of polycationic complexes of an antisense oligonucleotide in rat small intestine homogenates.
    González Ferreiro M; Crooke RM; Tillman L; Hardee G; Bodmeier R
    Eur J Pharm Biopharm; 2003 Jan; 55(1):19-26. PubMed ID: 12551700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense phosphorothioate oligodeoxyribonucleotide targeted against ICAM-1: synthetic and biological characterization of a process-related impurity formed during oligonucleotide synthesis.
    Ravikumar VT; Capaldi DC; Lima WF; Lesnik E; Turney B; Cole DL
    Bioorg Med Chem; 2003 Oct; 11(21):4673-9. PubMed ID: 14527564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.